Source: PharmacoEconomics and Outcomes News, Volume 1, Number 414, 2003 , pp. 12-12(1)
Publisher: Adis International
Keywords: Cost-allocation; Gefitinib, therapeutic use; HIV-infections, treatment; Lamivudine/zidovudine, therapeutic use; Non-small-cell-lung-cancer, treatment; Pharmaceutical-industry
Language: English
Document Type: Short communication
Links for this article